Longo

Sacramento Bee recently featured Professor Valter Longo’s research on the benefits of wheat germ.

Longo’s research shows early evidence that the wheat germ compound, spermidine, can replace “old or damaged parts of your cells with new versions.”

Woman’s World featured Valter Longo on the benefits of intermittent fasting.

NBC News, U.S. News & World Report,  and Yahoo News featured Valter Longo on how caloric restriction could affect health and aging. Longo said long-term restriction should be approached with caution: “It may cause powerful anti-aging effects, but also probably some degree of frailty or other issues that may not be so beneficial,” Longo said.

National Geographic interviewed Valter Longo about his research on fasting, fasting-mimicking diets, and how diet affects lifespan and healthspan. “When we talk to centenarians we often hear, ‘You know, we went through moments, through times, where there was just no food at all,’” he says.

The Week (India) featured research by Valter Longo on the optimal diet for a longer, healthier life.

The Scientist featured Valter Longo as a guest on The Scientist Speaks podcast, where he discussed how diet plays an important role in preventing inflammation, diabetes, and cognitive decline and how fasting and fasting-like diets appear to promote stem cell regeneration.

El País (Spain) interviewed Valter Longo regarding his research on fasting, metabolism and health. “We’ve done a large review of studies, analyzing data from two million people around the world. It’s clear that, by eating a lot of vegetables, whole grains and nuts, while avoiding red or processed meats, you can lengthen your life. If you add intermittent fasting to the mix, I think we can live 20 years longer,” he said.

SCIENMAG mentioned Valter Longo for his work looking at dietary strategies as part of cancer treatments. “We have been studying strategies that mimic fasting to fight cancer for years, with good results; we are now moving to the phase where oncologists are beginning to consider its use in combination with standard therapies,” he said. “The interesting thing is that it seems to work with very different cancers and in combination with different therapies. So it looks like a very promising approach.”